Regen Therapy forms health partnerships
Analysis based on 7 articles · First reported Apr 09, 2026 · Last updated Apr 09, 2026
The partnerships between Regenerative medicine, Stealth Health, and ZEO ScientifiX are expected to create a vertically integrated ecosystem for longevity and regenerative care, potentially driving new revenue for participating clinics and expanding the market for advanced biologic therapeutics. ZEO ScientifiX, as a publicly traded company, could see a positive impact on its stock price due to its central role as an exclusive supplier.
Regenerative medicine has formed strategic partnerships with Stealth Health and ZEO ScientifiX to create a vertically integrated ecosystem for longevity and regenerative care. The collaboration with Stealth Health will provide Regenerative medicine's network of over 3,000 clinics and 24,000 practitioners with scalable, white-label telemedicine services, including a licensed prescriber network and pharmacy fulfillment. Concurrently, Regenerative medicine has entered into an exclusive scientific and biologics strategic collaboration with ZEO ScientifiX, positioning ZEO ScientifiX as the core supplier of advanced biologic therapeutics for Regenerative medicine's platform. This initiative aims to enable clinics to deliver comprehensive, data-driven longevity and regenerative care at scale, integrating Metabolic Code's precision health platform for personalized assessments. The partnerships are designed to remove regulatory and operational barriers for clinics, allowing them to expand into high-demand specialized services and meet the accelerating demand for proactive, personalized health solutions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard